﻿<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.0">
  <channel>
    <title>HL - Commercial Litigation</title>
    <link>https://www.hoganlovells.com/en/service/commercial</link>
    <description>Hogan Lovells Commercial Litigation News and Publications</description>
    <language>en-us</language>
    <copyright>2016</copyright>
    <pubDate>21 Mar 2016</pubDate>
    <lastBuildDate>21 Mar 2016</lastBuildDate>
    <item>
      <title>Latest thinking and events</title>
    </item>
    <item>
      <title>Hogan Lovells advises Recordati on its strategic collaboration with Moderna</title>
      <description><![CDATA[Global law firm Hogan Lovells has advised Recordati on its strategic collaboration and license agreement with Moderna to develop and commercialize worldwide mRNA-3927, an investigational...]]></description>
      <link>https://www.hoganlovells.com/en/news/hogan-lovells-advises-recordati-on-its-strategic-collaboration-with-moderna</link>
      <category>Press releases</category>
      <guid>{BA8E3982-C415-4CFE-BD17-BB48458287C4}</guid>
      <pubDate>03 Feb 2026</pubDate>
      <lastBuildDate>03 Feb 2026</lastBuildDate>
    </item>
    <item>
      <title>Hogan Lovells advises Recordati on the agreements for the acquisition of the manufacturing and commercialization rights to Inrebic® in Japan</title>
      <description><![CDATA[Global law firm Hogan Lovells has advised Recordati on the agreements for the acquisiton from Impact Biomedicines &ndash; a company wholly owned by Bristol-Myers Squibb K.K. &ndash; of the...]]></description>
      <link>https://www.hoganlovells.com/en/news/hogan-lovells-advises-recordati-on-the-agreements-for-the-acquisition-of-the-manufacturing-and-commercialization-rights-to-inrebic-in-japan</link>
      <category>Press releases</category>
      <guid>{7F487856-A475-4A0A-AF1B-1FC790CD8CFC}</guid>
      <pubDate>19 Dec 2025</pubDate>
      <lastBuildDate>19 Dec 2025</lastBuildDate>
    </item>
    <item>
      <title>APAC Private Funds Market Developments and Outlook</title>
      <description><![CDATA[<p> Hogan Lovells and CSC are delighted to invite you to our APAC Private Funds Market Developments and Outlook event on Thursday, 13 November 2025. The event will explore the latest...</p>]]></description>
      <link>https://www.hoganlovells.com/en/events/apac-private-funds-market-developments-and-outlook</link>
      <category>Hogan Lovells Events</category>
      <guid>{F8678C0C-AD48-45B4-B28C-88729CA38BC1}</guid>
      <pubDate>13 Nov 2025</pubDate>
      <lastBuildDate>13 Nov 2025</lastBuildDate>
    </item>
    <item>
      <title><![CDATA[Podcast: Talking the Cure]]></title>
      <description><![CDATA[<p>Our team is always thinking about how to foresee and conquer the most significant industry issues facing our clients. In 2020, we launched the podcast "Talking the Cure" where we cover...</p>]]></description>
      <link><![CDATA[https://www.hoganlovells.com/en/publications/talking-the-cure]]></link>
      <category>News</category>
      <guid>{A2FAD327-643C-47BF-8D88-72DF22843BF6}</guid>
      <PublicationType>News</PublicationType>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/digicure-ai-american-health-whats-changing-now]]></category>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/white-house-launches-efforts-to-accelerate-artificial-intelligence-innovation-strengthen]]></category>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/the-data-chronicles-the-trump-administration-ai]]></category>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/fda-medical-device-inspections-in-2025]]></category>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/fda-releasing-complete-response-letters-for-drugs-and-biologics-that-have-not-yet-been-approved]]></category>
      <category domain="related material"><![CDATA[https://www.hoganlovells.com/en/publications/fda-enforcement-against-seniorlife-whoop-signal-new-line-in-the-sand-for-ai-health-apps]]></category>
      <author><![CDATA[melissa.bianchi@hoganlovells.com (Melissa Bianchi) | cybil.roehrenbeck@hoganlovells.com (Cybil Roehrenbeck) | sally.gu@hoganlovells.com (Sally Gu) | christopher.middendorf@hoganlovells.com (Christopher Middendorf) | josh.gelula@hoganlovells.com (Josh Gelula) | alice.valder.curran@hoganlovells.com (Alice Valder Curran) | arne.thiermann@hoganlovells.com (Arne Thiermann, LL.M. (LSE)) | ina.brock@hoganlovells.com (Ina Brock) | robert.church@hoganlovells.com (Robert Church) | stephanie.agu@hoganlovells.com (Stephanie Agu) | graham.cutts@hoganlovells.com (Graham Cutts) | michael.kasser@hoganlovells.com (Michael Kasser) | andreas.vonfalck@hoganlovells.com (Andreas von Falck) | jonathan.kahan@hoganlovells.com (Jonathan Kahan) | tina.welter@hoganlovells.com (Tina Welter-Birk) | komal.nigam@hoganlovells.com (Komal Nigam) | christian.dimauro@hoganlovells.com (Christian Di Mauro) | thierry.meillat@hoganlovells.com (Thierry Meillat) | stefan.martin@hoganlovells.com (Stefan Martin) | eckard.schwarz@hoganlovells.com (Eckard Schwarz) | zachary.siegel@hoganlovells.com (Zachary Siegel) | mike.druckman@hoganlovells.com (Michael Druckman) | david.horowitz@hoganlovells.com (David Horowitz) | jason.lohr@hoganlovells.com (Jason Lohr) | imogen.ireland@hoganlovells.com (Imogen Ireland) | randy.prebula@hoganlovells.com (Randy Prebula) | erkang.ai@hoganlovells.com (Erkang Ai) | jonathan.wasserman@hoganlovells.com (Jonathan Wasserman) | joy.sturm@hoganlovells.com (Joy Sturm) | mike.heyl@hoganlovells.com (Michael Heyl) | marion.palmer@hoganlovells.com (Dr. Marion Palmer) | rachel.gribben@hoganlovells.com (Rachel Gribben) | william.ferreira@hoganlovells.com (William Ferreira) | brooke.bumpers@hoganlovells.com (Brooke Bumpers) | nikolas.zirngibl@hoganlovells.com (Nikolas Zirngibl) | jane.summerfield@hoganlovells.com (Jane Summerfield) | hein.vandenbos@hoganlovells.com (Hein van den Bos) | Charlotte.damiano@hoganlovells.com (Charlotte Damiano) | joerg.schickert@hoganlovells.com (Jörg Schickert) | ashleigh.gray@hoganlovells.com (Ashleigh Gray) ]]></author>
      <pubDate>20 Oct 2025 00:00:00</pubDate>
      <lastBuildDate>20 Oct 2025 00:00:00</lastBuildDate>
    </item>
    <item>
      <title>Ready, Set, Comply: Practical Steps for SOPO Implementation</title>
      <description><![CDATA[<p>We are delighted to invite you to our seminar &ldquo;Ready, Set, Comply: Practical Steps for SOPO Implementation&rdquo;, on the new Construction Industry Security of Payment Ordinance (Cap. ...</p>]]></description>
      <link>https://www.hoganlovells.com/en/events/ready-set-comply-practical-steps-for-sop-implementation</link>
      <category>Hogan Lovells Events</category>
      <guid>{EB855D53-5AFF-482C-8EA0-F724811C555C}</guid>
      <pubDate>16 Oct 2025</pubDate>
      <lastBuildDate>16 Oct 2025</lastBuildDate>
    </item>
    <item>
      <title>Select Hong Kong 2025</title>
      <description><![CDATA[<p>We are delighted to invite you to join our second annual senior in-house legal conference, Select Hong Kong 2025. This event will be held from 8:45 a.m. to 3:30 p.m. on Tuesday, 14 October...</p>]]></description>
      <link>https://www.hoganlovells.com/en/events/select-hong-kong-2025</link>
      <category>Hogan Lovells Events</category>
      <guid>{F12EFB5C-82EB-4275-9A89-AB08DA7B7DCC}</guid>
      <pubDate>14 Oct 2025</pubDate>
      <lastBuildDate>14 Oct 2025</lastBuildDate>
    </item>
    <item>
      <title>IAA Mobility 2025</title>
      <description><![CDATA[<strong>Explore the Future of Mobility with us at IAA Mobility 2025<br />
</strong><br />
From September 9 to 14, 2025, the city of Munich will once again transform into a unique mobility festival, bringing together...]]></description>
      <link>https://www.hoganlovells.com/en/events/iaa-mobility-2025</link>
      <category />
      <guid>{32DA4570-CE89-4F34-A958-948C52AB2783}</guid>
      <pubDate>14 Sep 2025</pubDate>
      <lastBuildDate>14 Sep 2025</lastBuildDate>
    </item>
    <item>
      <title>Hogan Lovells advises Istituto Gentili on the exclusive partnership with CStone Pharmaceuticals</title>
      <description><![CDATA[<span>Global law firm Hogan Lovells has advised Istituto Gentili, a biopharmaceutical company rapidly expanding in the field of oncology </span><span>at European Level</span><span>, on an exclusive partnership with CStone ...</span>]]></description>
      <link>https://www.hoganlovells.com/en/news/hogan-lovells-advises-istituto-gentili-on-the-exclusive-partnership-with-cstone-pharmaceuticals</link>
      <category>Press releases</category>
      <guid>{BE9503EC-7042-474F-B1C9-FA6BCD929F2B}</guid>
      <pubDate>25 Jul 2025</pubDate>
      <lastBuildDate>25 Jul 2025</lastBuildDate>
    </item>
    <item>
      <title>Hogan Lovells APAC Life Sciences and Health Care Webinar Series - Spotlight on the U.S. - Session 8</title>
      <description><![CDATA[<p>Webinar No.8: US IPOs for life sciences companies</p>]]></description>
      <link>https://www.hoganlovells.com/en/events/hogan-lovells-apac-life-sciences-and-health-care-webinar-series-spotlight-on-the-us</link>
      <category>Webinar</category>
      <guid>{28CB4E1E-CF63-4BA9-9D0C-1E737488EA54}</guid>
      <pubDate>08 Jul 2025</pubDate>
      <lastBuildDate>08 Jul 2025</lastBuildDate>
    </item>
    <item>
      <title>Hogan Lovells advises Recordati on licensing and supply agreements with Amarin for the commercialization of Vazkepa®</title>
      <description><![CDATA[<p><em>Milan, London</em><em> 28 June 2025</em> &ndash; Global law firm Hogan Lovells has advised Recordati on the licensing and supply agreements with Amarin for the commercialization of the cardiovascular...</p>]]></description>
      <link>https://www.hoganlovells.com/en/news/hogan-lovells-advises-recordati-on-licensing-and-supply-agreements-with-amarin-for-the-commercialization-of-vazkepa</link>
      <category>Press releases</category>
      <guid>{E56FCE3F-F598-4237-9338-48C608C29A76}</guid>
      <pubDate>26 Jun 2025</pubDate>
      <lastBuildDate>26 Jun 2025</lastBuildDate>
    </item>
    <item>
      <title>MOVE London</title>
      <description><![CDATA[<p>For the 6th time Hogan Lovells is partnering with MOVE London, a tech mobility event that brings together people and companies redefining mobility. Our Hogan Lovells global MOVE team is...</p>]]></description>
      <link>https://www.hoganlovells.com/en/events/move-london-2025</link>
      <category>Sponsorships and Speaking Engagements</category>
      <guid>{6AFAECD8-7ED1-412D-9249-D74DD7C3B6AD}</guid>
      <pubDate>18 Jun 2025</pubDate>
      <lastBuildDate>18 Jun 2025</lastBuildDate>
    </item>
  </channel>
</rss>